Buğra Türkoğlu

Buğra Türkoğlu

Auto-generated profile, based on publicly available information

Buğra Türkoğlu

Department of Orthopedics and Traumatology, Dr. Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital, Ankara, Türkiye

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2025 in Joint Diseases and Related Surgery
Verified
Journal Article
Open access
İKİbrahim Kaya
İbrahim Kaya
MÇMustafa Çeltik
Mustafa Çeltik
SYSemih Yaş
Semih Yaş
SYSamet Batuhan Yoğurt
Samet Batuhan Yoğurt
BTBuğra Türkoğlu
Buğra Türkoğlu
ŞAŞefik Murat Arıkan
Şefik Murat Arıkan
This study aims to evaluate kinesiophobia and anxiety levels in patients with benign and benign-aggressive bone tumors located in the lower extremities. Between January 2022 and June 2024, a total of 54 patients (23 males, 31 females; mean age: 35.2±14.5 years; range, 15 to 67 years) who underwent surgery for benign and benign-aggressive bone tumors in the lower extremities were retrospectively analyzed. Of the patients, 16 developed pathological fractures and 38 did not. Kinesiophobia was assessed using the Tampa Kinesiophobia Scale (TKS), and anxiety levels were measured using the State-Trait Anxiety Inventory (STAI-I and STAI-II). Pathological fractures occurred in 29.6% of cases. The most common tumor types were enchondroma (44.4%), giant cell tumor (18.5%), and aneurysmal bone cyst (11.2%). Patients with pathological fractures had significantly higher TKS, STAI-I, and STAI-II scores than those without fractures (p<0.001, p=0.034, and p<0.001, respectively). In benign and benign-aggressive musculoskeletal lesions of the lower extremity, implementing prophylactic surgical intervention by predicting fracture risk reduces patients' levels of kinesiophobia and anxiety. Preventing pathological fractures in weight-bearing long bones allows for early mobilization, prevents fracture-related complications, and helps to preserve psychological well-being.

13 November 2026 in Harran Üniversitesi Tıp Fakültesi Dergisi
Verified
Journal Article
Open access
SYSemih Yaş
Semih Yaş
AAAsim Ahmadov
Asim Ahmadov
BTBuğra Türkoğlu
Buğra Türkoğlu
RBResul Bircan
Resul Bircan
İKİbrahim Kaya
İbrahim Kaya
CUCoşkun Ulucaköy
Coşkun Ulucaköy
Objective: Osteoid osteoma causes intense nocturnal pain that severely disrupts sleep. Although pain relief after definitive treatment is well known, the magnitude and clinical meaningfulness of sleep improvement remain unquantified. We aimed to establish disease-specific patient-reported benchmarks for sleep recovery after treatment for osteoid osteoma.Materials and Methods: Retrospective analysis of a prospectively maintained database with a prospective follow-up component for anchor-based analysis. Twenty-seven patients (median age, 22 years) treated surgically or with radiofrequency ablation were assessed using the PROMIS Sleep Disturbance Short Form 8b at baseline, 6 months, and 12 months. Longitudinal change was analyzed via a linear mixed-effects model, and anchor-based receiver operating characteristic (ROC) analysis was used to determine MCID, SCB, and PASS thresholds.Results: Median PROMIS T-scores improved from 63.7 (IQR 62.6-64.9) preoperatively to 28.9 (IQR 28.9-35.9) at 12 months (β=-0.61; p<0.001). The anchor-based MCID was a decrease ≥18.0 points, the SCB ≥28.1 points, and the PASS ≤47.4. Overall, 81.5% achieved at least MCID and 74% achieved SCB.Conclusion: Definitive treatment yields profound and sustained improvement in sleep quality. These preliminary benchmarks, which require external validation in larger cohorts, reflect the near-total symptom resolution unique to this condition and highlight the need for disease-specific patient-reported outcome measures.